DK1403266T3 - Fremgangsmåde til industriel fremstilling af strontiumranelat og hydrater heraf - Google Patents

Fremgangsmåde til industriel fremstilling af strontiumranelat og hydrater heraf

Info

Publication number
DK1403266T3
DK1403266T3 DK03292319.5T DK03292319T DK1403266T3 DK 1403266 T3 DK1403266 T3 DK 1403266T3 DK 03292319 T DK03292319 T DK 03292319T DK 1403266 T3 DK1403266 T3 DK 1403266T3
Authority
DK
Denmark
Prior art keywords
hydrates
industrial manufacture
strontium ranelate
ranelate
strontium
Prior art date
Application number
DK03292319.5T
Other languages
English (en)
Inventor
Lucile Vaysse-Ludot
Jean-Pierre Lecouve
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1403266T3 publication Critical patent/DK1403266T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DK03292319.5T 2002-09-24 2003-09-22 Fremgangsmåde til industriel fremstilling af strontiumranelat og hydrater heraf DK1403266T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Publications (1)

Publication Number Publication Date
DK1403266T3 true DK1403266T3 (da) 2014-07-07

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03292319.5T DK1403266T3 (da) 2002-09-24 2003-09-22 Fremgangsmåde til industriel fremstilling af strontiumranelat og hydrater heraf

Country Status (38)

Country Link
US (1) US7214805B2 (da)
EP (1) EP1403266B1 (da)
JP (1) JP4136867B2 (da)
KR (1) KR100551501B1 (da)
CN (1) CN1212321C (da)
AP (1) AP1910A (da)
AR (1) AR041355A1 (da)
AU (2) AU2003282179A1 (da)
BR (1) BR0304213A (da)
CA (1) CA2442878C (da)
CR (1) CR7764A (da)
CY (1) CY1115162T1 (da)
DK (1) DK1403266T3 (da)
EA (1) EA007489B1 (da)
EC (1) ECSP055741A (da)
ES (1) ES2478620T3 (da)
FR (1) FR2844795B1 (da)
GE (1) GEP20074215B (da)
HK (1) HK1065791A1 (da)
HR (1) HRP20050359B1 (da)
IL (1) IL167316A (da)
IS (1) IS7807A (da)
MA (1) MA26102A1 (da)
ME (1) ME00455B (da)
MX (1) MXPA03008643A (da)
MY (1) MY134921A (da)
NO (1) NO328638B1 (da)
NZ (1) NZ528402A (da)
OA (1) OA12934A (da)
PL (1) PL214400B1 (da)
PT (1) PT1403266E (da)
RS (2) RS20050240A (da)
SG (1) SG110071A1 (da)
SI (1) SI1403266T1 (da)
TN (1) TNSN05087A1 (da)
UA (1) UA79156C2 (da)
WO (1) WO2004029036A1 (da)
ZA (1) ZA200307409B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1534305T3 (pl) * 2003-05-07 2007-03-30 Osteologix As Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie
PL2266584T3 (pl) * 2003-05-07 2013-02-28 Osteologix As Kompozycja ze strontem i witaminą D do profilaktyki i/lub leczenia chorób chrząstki i/lub kości
AU2005216596B2 (en) * 2004-02-26 2011-03-24 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
EP1744770A2 (en) * 2004-05-06 2007-01-24 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
ATE443541T1 (de) 2004-06-25 2009-10-15 Strontin Aps Zusammensetzungen mit strontium und vitamin d und ihre verwendungen
FR2875807B1 (fr) 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
WO2007020527A2 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
US9301945B2 (en) 2011-07-21 2016-04-05 Emory University Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
ES2505716T3 (es) 2013-01-21 2015-09-04 Galenicum Health S.L. Composiciones farmacéuticas que comprenden una sal de ácido
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Also Published As

Publication number Publication date
KR20040026625A (ko) 2004-03-31
SI1403266T1 (sl) 2014-06-30
EA200300925A1 (ru) 2004-04-29
MA26102A1 (fr) 2004-04-01
NZ528402A (en) 2004-07-30
HRP20050359B1 (hr) 2014-09-26
ES2478620T3 (es) 2014-07-22
EP1403266A1 (fr) 2004-03-31
GEP20074215B (en) 2007-10-10
IL167316A (en) 2008-08-07
JP2004149516A (ja) 2004-05-27
AU2003282179A1 (en) 2004-04-19
ECSP055741A (es) 2005-07-06
AR041355A1 (es) 2005-05-11
AP2005003256A0 (en) 2005-03-31
RS20050240A (en) 2007-06-04
US20040063972A1 (en) 2004-04-01
CA2442878C (fr) 2009-03-03
CN1212321C (zh) 2005-07-27
AP1910A (en) 2008-10-30
UA79156C2 (en) 2007-05-25
NO328638B1 (no) 2010-04-12
ME00455B (me) 2011-10-10
BR0304213A (pt) 2004-08-31
EA007489B1 (ru) 2006-10-27
TNSN05087A1 (fr) 2007-05-14
MY134921A (en) 2008-01-31
IS7807A (is) 2005-04-19
EP1403266B1 (fr) 2014-04-09
HK1065791A1 (en) 2005-03-04
US7214805B2 (en) 2007-05-08
ZA200307409B (en) 2004-07-07
CY1115162T1 (el) 2016-12-14
AU2003248281B2 (en) 2009-08-06
FR2844795A1 (fr) 2004-03-26
WO2004029036A1 (fr) 2004-04-08
JP4136867B2 (ja) 2008-08-20
PL362365A1 (en) 2004-04-05
SG110071A1 (en) 2005-04-28
KR100551501B1 (ko) 2006-02-13
FR2844795B1 (fr) 2004-10-22
PL214400B1 (pl) 2013-07-31
RS53509B1 (en) 2015-02-27
MXPA03008643A (es) 2005-04-19
CN1496986A (zh) 2004-05-19
OA12934A (en) 2006-10-13
HRP20050359A2 (en) 2005-06-30
NO20034235D0 (no) 2003-09-23
CA2442878A1 (fr) 2004-03-24
AU2003248281A1 (en) 2004-04-08
PT1403266E (pt) 2014-05-06
NO20034235L (no) 2004-03-25
CR7764A (es) 2005-10-06

Similar Documents

Publication Publication Date Title
DK1403266T3 (da) Fremgangsmåde til industriel fremstilling af strontiumranelat og hydrater heraf
DK1651839T3 (da) Afstands- og sprossestykker til isolering af glasenheder
CY2015015I1 (el) Παραγωγη τιακουμυκινης
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DK1644384T3 (da) Fremgangsmåde og mellemprodukter til syntese af entecavir
NO20034212L (no) Kvartsglasskomponent og fremstilling derav
NO20021559L (no) Fremgangsmåte til gjenvinning av ammoniakk
DK1641832T3 (da) Fremgangsmåde til fremstilling af fiberholdig pektin og produkter og anvendelser heraf
DK1368028T3 (da) Benzimidazolforbindelser til IgE-modulering og inhibering af cellulær profi-ferering
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
DE60218800D1 (de) Hochtemperaturdichtung
DK1400522T3 (da) Forbindelser til behandling af impotens
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi
DK1472412T3 (da) Byggesæt af brosten
DK1670773T3 (da) Fremgangsmåde til fremstilling af benzoxazol-sulfonamidforbindelser og mellemprodukter deraf
DK1309583T3 (da) Fremgangsmåde til fremstilling af discodermolid og analoge deraf
DK1373245T3 (da) Mellemprodukter til fremstilling af spinosyner
DK1370504T3 (da) Fremgangsmåde til fremstilling af bygningselementer
NO20031258D0 (no) Prosjektil og fremgangsmåte for tilvirkning derav
FI20021941A0 (fi) Avoimen rakentamisen tehokkaampi toteuttaminen
FI20021940A0 (fi) Avoimen rakentamisen tehokkaampi toteuttaminen
ATA15602002A (de) Ziegeldecke
FI20011716A0 (fi) Menetelmä elohopean talteenottamiseksi
FI20020516A0 (fi) Menetelmä elohopean talteenottamiseksi
ATA14982002A (de) Ziegel